SIEBERT JOHN M 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 26, 2024
Insider Transaction Report
Form 4
SIEBERT JOHN M
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2024-02-22+8,252→ 8,252 totalExercise: $27.94Exp: 2034-02-22→ Common Stock (8,252 underlying) - Award
Restricted Stock Units
2024-02-22+5,369→ 5,369 total→ Common Stock (5,369 underlying)
Holdings
- 84,057
Common Stock
Footnotes (3)
- [F1]The option vests on February 22, 2025.
- [F2]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F3]These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025.